Jai is a drug researcher, harm reduction advocate and drug user interested in a broad range of health research topics. He is particularly interested in research that pertains to harm reduction, drug policy, lived and living experience, and the intersection of these areas and Te Ao Māori

Daniel Sherman is a PhD candidate in philosophy at the University of Western Australia. His research examines psychedelic epistemology, interoception, and addiction. Drawing on philosophy of mind and cognitive science, he develops a naturalistic account of how altered states can yield clinically relevant forms of self-knowledge and behavioral change.

Danielle is a PhD candidate at the National Centre for Youth Substance Use Research. Her clinical experience in the field of psychology has led to a deep interest in cannabis and public health. Her research investigates the epidemiology of medicinal cannabis in Australia.

Antoni Pazeski is an early career researcher working at Hunter New England Local health district, working on qualitative and quantitative studies in drug and alcohol addiction. Arshman S Sahid early career researcher working at South East Sydney Local health district working on clinical trials in addiction.

Sam is a PhD candidate at the University of Auckland researching psilocybin mushroom use in Aotearoa through a harm‑reduction lens. He is also national coordinator of Students for Sensible Drug Policy Aotearoa, a Psilver Linings NZ board member, and member of Harm Reduction Coalition Aotearoa and the Global Psychedelics Consortium.

Anjali is a Clinical Trial Lead at the University of Sydney and a research expert at leading clinical trials with Medicinal Cannabis.